Literature DB >> 21959007

Nanoprobes for in vitro diagnostics of cancer and infectious diseases.

Xiaoqin Chi1, Dengtong Huang, Zhenghuan Zhao, Zijian Zhou, Zhenyu Yin, Jinhao Gao.   

Abstract

The successful and explosive development of nanotechnology is significantly impacting the fields of biology and medicine. Among the spectacular developments of nanobiotechnology, interest has grown in the use of nanomaterials as nanoprobes for bioanalysis and diagnosis. Herein, we review state-of-the-art nanomaterial-based probes and discuss their applications in in vitro diagnostics (IVD) and challenges in bringing these fields together. Major classes of nanoprobes include quantum dots (QDs), plasmonic nanoparticles, magnetic nanoparticles, nanotubes, nanowires, and multifunctional nanomaterials. With the advantages of high volume/surface ratio, surface tailorability, multifunctionality, and intrinsic properties, nanoprobes have tremendous applications in the areas of biomarker discovery, diagnostics of infectious diseases, and cancer detection. The distinguishing features of nanoprobes for in vitro use, such as harmlessness, ultrasensitivity, multiplicity, and point-of-care use, will bring a bright future of nanodiagnosis. Copyright Â
© 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21959007     DOI: 10.1016/j.biomaterials.2011.09.032

Source DB:  PubMed          Journal:  Biomaterials        ISSN: 0142-9612            Impact factor:   12.479


  20 in total

1.  Multifunctional magnetic rotator for micro and nanorheological studies.

Authors:  Alexander Tokarev; Alexey Aprelev; Mikhail N Zakharov; Guzeliya Korneva; Yury Gogotsi; Konstantin G Kornev
Journal:  Rev Sci Instrum       Date:  2012-06       Impact factor: 1.523

Review 2.  Nanoformulated Antiretrovirals for Penetration of the Central Nervous System: State of the Art.

Authors:  Luisa Fiandra; Amedeo Capetti; Luca Sorrentino; Fabio Corsi
Journal:  J Neuroimmune Pharmacol       Date:  2016-11-10       Impact factor: 4.147

Review 3.  Point-of-care testing in the diagnosis of gastrointestinal cancers: current technology and future directions.

Authors:  Jeremy R Huddy; Melody Z Ni; Sheraz R Markar; George B Hanna
Journal:  World J Gastroenterol       Date:  2015-04-14       Impact factor: 5.742

Review 4.  Biomaterials and emerging anticancer therapeutics: engineering the microenvironment.

Authors:  Luo Gu; David J Mooney
Journal:  Nat Rev Cancer       Date:  2016-01       Impact factor: 60.716

Review 5.  Techniques for physicochemical characterization of nanomaterials.

Authors:  Ping-Chang Lin; Stephen Lin; Paul C Wang; Rajagopalan Sridhar
Journal:  Biotechnol Adv       Date:  2013-11-16       Impact factor: 14.227

6.  Anticancer effect of selenium/chitosan/polyethylene glycol/allyl isothiocyanate nanocomposites against diethylnitrosamine-induced liver cancer in rats.

Authors:  Cheng Li; Saleh H Salmen; Tahani Awad Alahmadi; Vishnu Priya Veeraraghavan; Krishna Mohan Surapaneni; Nandakumar Natarajan; Senthilkumar Subramanian
Journal:  Saudi J Biol Sci       Date:  2022-02-11       Impact factor: 4.052

Review 7.  A Comparison of Optical, Electrochemical, Magnetic, and Colorimetric Point-of-Care Biosensors for Infectious Disease Diagnosis.

Authors:  Oleksandra Pashchenko; Tyler Shelby; Tuhina Banerjee; Santimukul Santra
Journal:  ACS Infect Dis       Date:  2018-06-18       Impact factor: 5.084

Review 8.  Nanotechnology-based approaches in anticancer research.

Authors:  Nasimudeen R Jabir; Shams Tabrez; Ghulam Md Ashraf; Shazi Shakil; Ghazi A Damanhouri; Mohammad A Kamal
Journal:  Int J Nanomedicine       Date:  2012-08-09

Review 9.  Nanomedicine: a primer for surgeons.

Authors:  K K Y Wong; X L Liu
Journal:  Pediatr Surg Int       Date:  2012-08-15       Impact factor: 1.827

10.  Chemical and colloidal stability of carboxylated core-shell magnetite nanoparticles designed for biomedical applications.

Authors:  Márta Szekeres; Ildikó Y Tóth; Erzsébet Illés; Angéla Hajdú; István Zupkó; Katalin Farkas; Gábor Oszlánczi; László Tiszlavicz; Etelka Tombácz
Journal:  Int J Mol Sci       Date:  2013-07-12       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.